SOTROVIMAB
UNII 1MTK0BPN8V

Substance Identification & Data

This profile provides standardized clinical and technical data for Sotrovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1MTK0BPN8V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2423014-07-5 and the RxNorm Concept ID (RxCUI) 2550731. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1MTK0BPN8V

CAS Registry Number

2423014-07-5

RxNorm Concept ID

2550731

Detailed Substance Profile

Preferred Name

SOTROVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C177059

National Cancer Institute reference terminology for clinical and research data.

INN ID

11766

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sotrovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOTROVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7831 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-7831 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2)),HUMAN MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-457) (HOMO SAPIENS VH (IGHV1-18*01 (93%) (IGHD)-IGHJ5*01 (93%)) (8.8.20) (1-127)-HOMO SAPIENS IGHG1*01 (CH3(M88>L(438), N94>S(444)) (128-457)) (230-214')- DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-20*01 (94%) IGKJ4*01)(7.3.8) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (236-236'':239-239'')-BISDISULFIDE. POST-TRANSLATIONAL MODIFICATIONS: K (457) AND K (457'') DELETED, N (307) AND N (307'') GLYCOSYLATED

SOTROVIMAB [INN]

SOTROVIMAB [JAN]

SOTROVIMAB [USAN]

SOTROVIMAB [WHO-DD]